Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Warfarin

NCT03426033 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Elevated Lipoprotein(a)
Cardiovascular Diseases

Interventions

DRUG: ISIS 681257
DRUG: Warfarin

Sponsor

Akcea Therapeutics